Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × pazopanib × 90 days × Clear all

Sponsor

Conditions

Sarcoma 5 Carcinoma, Renal Cell 4 Sarcoma, Clear Cell 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Solid Neoplasm 1 Smooth Muscle Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Perivascular Epithelioid Cell Neoplasms 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Liposarcoma, Myxoid 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Granular Cell Tumor 1 Glomus Tumor 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡